Novanta is trading 4% up at $157.73 as shares extend a recovery from the sharp sell-off on July 7.
- William Blair recently added the company to its July Analyst Conviction List, signaling strong confidence in its performance.
- Zacks Investment Research upgraded the stock to a Buy rating, further boosting investor optimism regarding upcoming earnings prospects after the recent pullback.